Condition

Venous Thromboembolism (VTE) clinical trials and research

• 19Clinical trials
• 1NIH research projects
• 1New in 30 days
• 20Countries

Newest Venous Thromboembolism (VTE) clinical trials

All recruiting trials (19)

• Aspirin vs. rivaroxaban for blood clot prevention in newly diagnosed multiple myeloma

  In newly diagnosed multiple myeloma patients on IMiD-based therapy, this study tests whether aspirin or rivaroxaban is better at preventing blood clots.

  Recruiting Phase 4 The First Affiliated Hospital with Nanjing Medical University · Nanjing, Jiangsu · NCT07907211

• TRiP-cast score test in adults with acute lower-limb injuries requiring immobilization

  This study tests whether the TRiP(cast) score can predict risk of blood clots in adults with acute lower-limb injuries treated as outpatients.

  Recruiting University of Monastir · Monastir · NCT07863115

• Pulmonary Embolism Registry from Emergency Care to Long-Term Follow-Up

  This registry follows adults with acute pulmonary embolism to see how care is given in the real world and what happens over time.

  Recruiting at 16 sites Azienda Ospedaliero-Universitaria Careggi · Bagno a Ripoli, Tuscany and 15 other locations · NCT07855679

• YKYY033 Injection safety and tolerability in adults

  This study tests whether a single dose of YKYY033 injection is safe and tolerable in healthy adults aged 18–55.

  Recruiting Phase 1 Youcare Pharmaceutical Group Co., Ltd. · Beijing, Beijing Municipality · NCT07786779

• Blood-clot prevention with REGN7508 and REGN9933 in people with PICC lines

  This study tests whether REGN7508 and REGN9933 can help prevent blood clots in people who have a PICC line.

  Recruiting Phase 3 Regeneron Pharmaceuticals · Tbilisi · NCT07697599

• Treatment and prevention of blood clots in adults with cancer

  This study tests REGN7508 against apixaban to see if it can treat and prevent blood clots in adults with or without cancer, including those with cancer-related clots in the legs and lungs.

  Recruiting at 12 sites Phase 3 Regeneron Pharmaceuticals · Hialeah, Florida and 13 other locations · NCT07493304

• Predicting blood clots after lung cancer surgery

  This project will try to use clinical, surgical, and lab data to predict which adults having lung cancer surgery may develop blood clots after the operation.

  Recruiting The First Hospital of Jilin University · Changchun, Jilin · NCT07439991

• Single-dose test of CITY-FXI in adults with and without Factor V Leiden or Prothrombin G20210A mutation

  This will test a single dose of CITY-FXI, an siRNA that lowers Factor XI, in healthy adults and in adults who carry Factor V Leiden or the prothrombin G20210A mutation to see if it is safe and how it acts in the body.

  Recruiting Phase 1 City Therapeutics · London · NCT07430397

• CLOVER score to find hidden cancer in people with venous blood clots

  This project will test whether the CLOVER score can help find undiagnosed cancer in adults who have had a symptomatic venous blood clot.

  Recruiting at 12 sites Infanta Leonor University Hospital · Barcelona, Barcelona and 11 other locations · NCT07310693

• How gene changes relate to clotting risk in advanced or metastatic non-small-cell lung cancer

  This project will test whether specific cancer gene changes are linked to blood-clotting markers and the risk of venous blood clots in people with advanced non-small-cell lung cancer.

  Recruiting University Of Perugia · Perugia, Perugia · NCT07288632

• Early exercise-based rehabilitation for adults hospitalized with acute pulmonary embolism

  This trial tries an early, supervised exercise and education program for adults hospitalized with acute pulmonary embolism to see if it prevents long-term breathlessness and improves quality of life.

  Recruiting at 6 sites Insel Gruppe AG, University Hospital Bern · Aarau and 5 other locations · NCT07143539

• Short course of low‑dose heparin to prevent postpartum blood clots

  This study will test whether a short 7–10 day course of low‑dose low‑molecular‑weight heparin after delivery reduces blood clots and how it affects bleeding and wound problems in postpartum women with certain risk factors.

  Recruiting at 9 sites Phase 3 University Hospital, Geneva · Baden and 8 other locations · NCT07140211

• REGN7508 versus apixaban and enoxaparin for preventing blood clots after total knee replacement

  This trial will test whether REGN7508 prevents blood clots after elective one-sided total knee replacement in adults compared with apixaban, enoxaparin, or placebo.

  Recruiting at 43 sites Phase 3 Regeneron Pharmaceuticals · Sheffield, Alabama and 46 other locations · NCT07015905

• Comparing Pulsed Electromagnetic Field Therapy and Pneumatic Compression for Preventing Blood Clots in ICU Patients

  This study is testing whether Pulsed Electromagnetic Field Therapy works better than pneumatic compression to prevent blood clots in ICU patients who can't take medication for it.

  Recruiting Phase 4 Science Valley Research Institute · Belo Horizonte, BH · NCT06958588

• Hip fracture thrombosis prevention: aspirin vs LMWH after surgery

  A large UK study tests whether aspirin or a daily LMWH shot works better to prevent blood clots after hip fracture surgery.

  Recruiting Queen Mary University of London · London · NCT06937372

• Preventing blood clots in postpartum women at intermediate risk

  This study is testing if giving a blood thinner to women at risk of blood clots after giving birth can help prevent those clots during the first six weeks postpartum.

  Recruiting at 2 sites Phase 4 University Hospital, Brest · Amiens and 17 other locations · NCT06845423

• Heat shock protein 47 in blood clot conditions

  This will test whether platelet levels of Heat Shock Protein 47 (HSP47) can help predict outcomes in adults with recent venous thromboembolism, ST-elevation myocardial infarction, or ischemic stroke compared with healthy volunteers.

  Recruiting at 2 sites University of Aarhus · Aarhus, Central Region and 1 other locations · NCT06731673

• Imaging active blood clots using PET technology

  This study is testing a new way to use PET scans to see active blood clots in people with conditions like deep vein thrombosis and pulmonary embolism, to help doctors decide who really needs blood-thinning treatment.

  Recruiting University Hospital, Brest · Brest · NCT06057844

• Evaluating and improving diagnostics and management of venous thromboembolism

  This study is trying to find better ways to diagnose and manage blood clots in the veins for older patients who might have deep vein thrombosis or pulmonary embolism.

  Recruiting Johannes Gutenberg University Mainz · Mainz, Rhineland-Palatinate · NCT02156401

NIH-funded research (1)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Understanding blood clot risks in children with sickle cell disease

  This study is looking at what might cause blood clots in children with sickle cell disease, so we can find better ways to prevent and treat these clots and help keep kids healthier.

  NIH research Johns Hopkins University · Baltimore, United States · NIH-10907804

Related topics

Quick answers

How many Venous Thromboembolism (VTE) clinical trials are recruiting right now?

19, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 20 countries. The most sites are in China (3 trials), Bulgaria (2 trials), Japan (2 trials), Poland (2 trials), Romania (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 4, Phase 4: 3, Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →